0B68 Hyslop, Terry - Thomas Jefferson University - Thomas Jefferson University
tmh102

Terry Hyslop, PhD

Contact Dr. Hyslop

1015 Chestnut Street
Suite M-100 Mezzanine
Philadelphia, PA 19107

(215) 503-7806
(215) 503-3804 fax

Most Recent Peer-reviewed Publications

  1. Overexpressing TNF-Alpha in Pancreatic Ductal Adenocarcinoma Cells and Fibroblasts Modifies Cell Survival and Reduces Fatty Acid Synthesis via Downregulation of Sterol Regulatory Element Binding Protein-1 and Activation of Acetyl CoA Carboxylase
  2. Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease
  3. Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma
  4. Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment
  5. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients
  6. Molecular staging of node negative patients with colorectal cancer
  7. Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
  8. A phase i study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas
  9. Population and target considerations for triple-negative breast cancer clinical trials
  10. Guanylyl cyclase C as a biomarker in colorectal cancer
  11. Early results of prostate cancer radiation therapy: An analysis with emphasis on research strategies to improve treatment delivery and outcomes
  12. A Dual-Institution Randomized Controlled Trial of Remnant Closure after Distal Pancreatectomy: Does the Addition of a Falciform Patch and Fibrin Glue Improve Outcomes?
  13. Circadian Gene Expression and Clinicopathologic Correlates in Pancreatic Cancer
  14. Genetic variations in stem cell-related genes and colorectal cancer prognosis
  15. Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
  16. Prognostic factors and outcomes after definitive treatment of female urethral cancer: A population-based analysis
  17. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma
  18. Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer
  19. GUCY2C molecular staging personalizes colorectal cancer patient management
  20. Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes
0